{
      "brief_title": [
            "phase",
            "iii",
            "study",
            "efficacy",
            "versus",
            "cell",
            "lung",
            "cancer",
            "patient"
      ],
      "brief_summary": [
            "taxotere",
            "approve",
            "fda",
            "consider",
            "standard",
            "treatment",
            "patient",
            "lung",
            "cancer",
            "fail",
            "prior",
            "regimen",
            "main",
            "purpose",
            "research",
            "study",
            "determine",
            "aptosyn",
            "give",
            "combination",
            "taxotere",
            "result",
            "prolong",
            "survival",
            "compare",
            "taxotere",
            "alone",
            "study",
            "also",
            "help",
            "determine",
            "tumor",
            "response",
            "rat",
            "safety",
            "profile",
            "aptosyn",
            "combination",
            "taxotere",
            "study",
            "complete",
            "publication",
            "pending"
      ],
      "condition": [
            "cell",
            "lung",
            "cancer"
      ],
      "intervention_type": [
            "Drug"
      ],
      "intervention_name": [
            "Exisulind"
      ],
      "criteria": [
            "exclusion",
            "criterion"
      ],
      "gender": "All",
      "minimum_age": [],
      "maximum_age": [],
      "healthy_volunteers": "No",
      "keyword": [
            "cell",
            "lung",
            "cancer"
      ],
      "mesh_term": [
            "neoplasm",
            "lung",
            "sulfone"
      ],
      "id": "NCT00085826"
}